Federal contractor · public award history
ORASURE TECHNOLOGIES INC
Parent: ORASURE TECHNOLOGIES INC Unique Entity Identifier (UEI)Y79RWFLHWDM6
- Awards we know about
- 5
- Typical size
- $8.18M
- Middle of their public awards
- Dollars on those awards
- $32.72M
Most of their awards we can see fall roughly between $4.52M and $11.83M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Feb 24, 2027
- Activation date
- Feb 26, 2026
- Primary NAICS (SAM)
- In-Vitro Diagnostic Substance Manufacturing325413
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (4)
- Department of Veterans Affairs (1)
Industries & product codes
Award history
- Department of Health and Human Services$15.50MSep 4, 2025Procurement Instrument Identifier (PIID)75A50122C00079Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A SECOND-GENERATION ASSAY FOR THE ORAQUICK EBOLA RAPID ANTIGEN TEST AS A SUSTAINABLE, ENHANCED TEST INCLUDING ALTERNATIVE REAGENTS (ANTIBODY AND ANTIGEN) WITH CONTINUED AVAILABILITY, EXTENDED SHELF-LIFE, A
- Department of Health and Human Services$10.61MSep 4, 2025Procurement Instrument Identifier (PIID)HHSO100201500009CNorth American Industry Classification System (NAICS)541711Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
IGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD, PLASMA,AND ORAL FLUID.
- Department of Health and Human Services$856,100Sep 3, 2025Procurement Instrument Identifier (PIID)75A50122P00014In-Vitro Diagnostic Substance Manufacturing325413In Vitro Diagnostic Substances, Reagents, Test Kits And Sets6550Contract awardUSAspending ↗
THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS.
- Department of Health and Human Services$5.75MNov 6, 2024Procurement Instrument Identifier (PIID)75A50223C00044In-Vitro Diagnostic Substance Manufacturing325413In Vitro Diagnostic Substances, Reagents, Test Kits And Sets6550Contract awardUSAspending ↗
OVER THE COUNTER (OTC) COVID-19 TESTS
- Department of Veterans Affairs—Oct 16, 2024Procurement Instrument Identifier (PIID)36F79722D0059In-Vitro Diagnostic Substance Manufacturing325413In Vitro Diagnostic Substances, Reagents, Test Kits And Sets6550Indefinite Delivery Vehicle (IDV)USAspending ↗
65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.